Measuring Disease Activity in Psoriatic Arthritis

Over the past decade, the assessment of the disease activity in psoriatic arthritis (PsA) has rapidly evolved in view of the need for valid, feasible, and reliable outcome measures that can be ideally employed in longitudinal cohorts, clinical trials, and clinical practice as well as the growing par...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Priscilla C. H., Leung, Ying-Ying, Li, Edmund K., Tam, Lai-Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3540792/
https://www.ncbi.nlm.nih.gov/pubmed/23319952
http://dx.doi.org/10.1155/2012/839425
Descripción
Sumario:Over the past decade, the assessment of the disease activity in psoriatic arthritis (PsA) has rapidly evolved in view of the need for valid, feasible, and reliable outcome measures that can be ideally employed in longitudinal cohorts, clinical trials, and clinical practice as well as the growing paradigm of tight disease control and treating to target in the management of PsA. This paper reviews the currently available measures used in the assessment of the disease activity in PsA. The composite measures for PsA that are under development are also discussed.

Ejemplares similares